Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework

NCT05134857 is registered in ClinicalTrials.gov with Washington State University as lead sponsor.

NCT NCT05134857
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05134857 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zonisamide for the Treatment of Alcohol Use Disorder in the Addiction Neuroclinical Assessment Framework
Lead sponsor
Washington State University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 7, 2022
Completion date
August 31, 2027
Enrollment
205 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)